Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Saving money doesn't have to be dull! Explore creative ways to keep your savings journey enjoyable and engaging.
28,655 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A quiet yet potent shift is happening in AI investing. This article reveals a dividend-friendly idea that few saw com...
Fox agreed to buy Roku for $22 billion, sending Roku stock to four-year highs and triggering debate over how the deal...
Trinidad and Tobago signed two memorandums of understanding with U.S. firms to move forward with large-scale data cen...
When a small-cap tech company reports results that miss expectations, the stock often takes a hit. This piece dives i...
A leading LNG stock jumped 32% this stock year, investor took profits, and a massive exit followed. Here’s how to und...
A new hybrid crypto platform blends self-custody with real-world asset yields, aiming to unite TradFi and DeFi within...
Tiffany James has been tapped to lead HAAR and ValleyMLS, the Huntsville-area trade group and its MLS, as North Alaba...
Promotional events like Prime Day grab headlines, but the real driver of Amazon stock is its cloud arm, AWS. This gui...
A fresh recall of magsafe battery chargers recalled details new fire hazards linked to lithium-ion cells, with refund...
Cathie Wood goes bargain isn’t a hype moment. It’s a disciplined approach to re-evaluating disrupted growth names aft...
Palantir stock isn't cheap, but its AI-driven data platform and strong government foothold create a long‑term thesis ...